Once upon a time stem cells were hailed as the cure for everything with their possibilities deemed as endless. Even new legislation had to be put in place as the debate for the stem cell research quickly engulfed most of the countries around the world. Now the topic has cooled down significantly but some companies still find their forte in the field.
Cord Blood America, Inc. (OTCBB:CBAI
) provides private umbilical cord blood stem cell preservation services to families and they seem to be doing pretty well for themselves. Their stock is actively traded and most often than not reaches tens of millions in volume although their price level has stagnated a bit during the last weeks. Yesterday’s movement broke this pattern as they climbed up by 23% to close at $0.0042.
If this will be a one time jump is hard to determine as the company isn’t prone to releasing any news statements about their business. At least their financial reports have been filed regularly. The latest one is the 10-K form for 2012 and CBAI
have the following numbers to show for themselves:
- $393 thousand cash
- $1 million total current assets
- $4 million total current liabilities
- $5.9 million revenues
still ended the year with a negative balance sheet but the progress they made cannot be denied. Their results have almost doubled those from 2011 with the reduction in net loss being the most impressive – from $6.5 million to $3.5 million.
A part in yesterday’s jump undoubtedly also played the small pump campaign initiated by the Stock Hideout. They time they have disclosed received no compensation for their services quite unlike their previous job just a couple of days ago for MineralRite Corporation (OTCMKTS:RITE
may very well be on the right track. They revised their business operations and have improved on almost all aspects of their operations. The only downside is the current promotion and the way it will affect the movement of the ticker. Before commiting to any trade be sure to weigh in all the risks and consider if they are acceptable for you.